NEW YORK, March 15, 2017 /PRNewswire/ --
On Tuesday, March 14, 2017, the NASDAQ Composite,the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Additionally, all nine sectors ended Tuesday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, Stock-Callers.com assessed
Brookdale Senior Living
Brentwood, Tennessee headquartered Brookdale Senior Living Inc.'s stock finished Tuesday's session 1.93% lower at $12.22 with a total volume of 3.43 million shares traded. The Company's shares are trading below its 50-day and 200-day moving averages by 15.82% and 20.37%, respectively. Shares of Brookdale Senior Living, which owns and operates senior living communities in the US, have a Relative Strength Index (RSI) of 20.73. See our free and comprehensive research report on BKD at: http://stock-callers.com/registration/?symbol=BKD
Nashville, Tennessee-based Envision Healthcare Corp.'s stock lost 2.01%, to close the day at $64.44. The stock recorded a trading volume of 1.70 million shares, which was above its three months average volume of 1.41 million shares. Envision Healthcare's shares have rallied 207.74% in the past one year. The Company's shares are trading 68.21% above its 200-day moving average. Shares of the Company, which through its subsidiaries, provides various healthcare services in the US, are trading at a PE ratio of 352.13. Additionally, the stock has an RSI of 38.71.
On March 01st, 2017, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with a decrease of the target price from $87 a share to $80 a share. EVHC free research report PDF is just a click away at: http://stock-callers.com/registration/?symbol=EVHC
On Tuesday, shares in Louisville, Kentucky headquartered Kindred Healthcare Inc. ended the session 3.57% lower at $8.10 with a total volume of 902,258 shares traded. Kindred Healthcare's shares have gained 20.79% in the last one month and 5.99% in the previous three months. The stock is trading 6.74% above its 50-day moving average. Moreover, shares of the Company, which provides healthcare services in the US, have an RSI of 49.95.
On February 28th, 2017, research firm Mizuho reiterated its 'Neutral' rating on the Company's stock with an increase of the target price from $5 a share to $8.50 a share. Sign up for your complimentary report on KND at: http://stock-callers.com/registration/?symbol=KND
On Tuesday, shares in Houston, Texas headquartered Nobilis Health Corp. recorded a trading volume of 1.23 million shares, which was higher than their three months average volume of 622,610 shares. The stock ended the day 6.25% lower at $1.50. Shares of the Company, which together with its subsidiaries, acquires and manages ambulatory surgical centers and healthcare facilities in the US, are trading at a PE ratio of 2.72. Nobilis Health's stock is trading below its 50-day and 200-day moving averages by 31.91% and 43.64%, respectively. Furthermore, Nobilis Health's shares have an RSI of 16.70. Register for free on Stock-Callers.com and download the latest research report on HLTH at: http://stock-callers.com/registration/?symbol=HLTH
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://stock-callers.com/legal-disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Immunotherapy is a type of treatment method that works by using certain components of a person's ...
Elderberry and its other plant parts provide an array of health benefits. Know how this fruit helps ...
Increasing weight and obesity are some of the most common health problems today. A smart weight ...View All